Literature DB >> 315433

Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate.

E A Grimm, J A Thoma, B Bonavida.   

Abstract

The kinetics and rate of T cell-mediated cytolysis was assessed by measuring the times required for lysis of isolated target cells by single cytotoxic lymphocytes. Single target cell lysis was determined microscopically by observing trypan blue uptake as a function of time of incubation of effector-target conjugates in agarose. Lysis of EL-4 target cells by alloimmune peritoneal exudate lymphocytes was initiated without a lag and was essentially complete at 2 hr. Both zero-order and first-order kinetics equations were analyzed for fit to the 0 to 2 hr lysis values. Statistically, the zero-order kinetic function could be rejected (p greater than 0.05), but the first-order kinetics function (p less than 0.01) could not. This strong evidence for first-order kinetics of T cell-mediated cytolysis implies that within each CTL-target cell population, cytolysis occurs exponentially as a random decay process and that one event in the entire process of cytolysis is rate limiting. The first-order equation was then applied to measurements of the rate of cytolysis in many different individual effector-target cell combinations. Significant differences in the lytic rate were apparent when either the effector or target cell were varied, with the rate constants spanning a 5-fold range. The heterogeneity of lytic rates is consistent with the hypothesis that lytic efficiency is a function of both the effector and target cells used.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315433

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Inhibition of human natural killer cell activity by Legionella pneumophila protease.

Authors:  C Rechnitzer; M Diamant; B K Pedersen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-11       Impact factor: 3.267

2.  Generation of natural killer cells from bone marrow precursors in vitro.

Authors:  T Kalland
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

3.  Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.

Authors:  B K Pedersen; P Oxholm
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

Review 4.  The human NK cell--a short over-view and an hypothesis on NK recognition.

Authors:  M Jondal
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Estimation of the rate of killing by cytotoxic T lymphocytes in vivo.

Authors:  Roland R Regoes; Daniel L Barber; Rafi Ahmed; Rustom Antia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-22       Impact factor: 11.205

6.  Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase.

Authors:  B K Pedersen; A Kharazmi
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

7.  Interferon and interleukin-2 induced spontaneous cell-mediated cytotoxicity: a preliminary evaluation.

Authors:  P Balaram; M R Pillai; T Abraham; K R Nalinakumari; G Meenattoor; S Kannan; N K Hareendran; M K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

8.  Murine natural killer cells are fungicidal to Cryptococcus neoformans.

Authors:  M R Hidore; N Nabavi; F Sonleitner; J W Murphy
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

9.  Antibody- and interferon-dependent killer cells are part of the NK cell receptor positive subpopulation of human peripheral blood cells.

Authors:  M Ullberg; M Jondal
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

10.  Herpesvirus ateles and herpesvirus saimiri transform marmoset T cells into continuously proliferating cell lines that can mediate natural killer cell-like cytotoxicity.

Authors:  D R Johnson; M Jondal
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.